Financhill
Back

Spero Therapeutics Stock Price Chart

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SPRO is experiencing slight selling pressure.

Spero Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 2.93 Buy
20-day SMA: 2.91 Buy
50-day SMA: 1.89 Buy
200-day SMA: 1.23 Buy
8-day EMA: 1.18 Buy
20-day EMA: 0.54 Buy
50-day EMA: 0.23 Buy
200-day EMA: 0.06 Buy

Spero Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.42 Buy
Relative Strength Index (14 RSI): 75.24 Buy
Chaikin Money Flow: -575015 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.72 - 2.98) Buy
Bollinger Bands (100): (0.37 - 2.27) Buy

Spero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Spero Therapeutics Stock

Is Spero Therapeutics Stock a Buy?

SPRO Technical Analysis vs Fundamental Analysis

Sell
47
Spero Therapeutics (SPRO) is a Sell

Is Spero Therapeutics a Buy or a Sell?

Spero Therapeutics Stock Info

Market Cap:
170M
Price in USD:
3.04
Share Volume:
1.7M

Spero Therapeutics 52-Week Range

52-Week High:
3.22
52-Week Low:
0.51
Sell
47
Spero Therapeutics (SPRO) is a Sell

Spero Therapeutics Share Price Forecast

Is Spero Therapeutics Stock a Buy?

  • Spero Therapeutics share price is 3.04 while SPRO 8-day exponential moving average is 1.18, which is a Buy signal.
  • The stock price of SPRO is 3.04 while Spero Therapeutics 20-day EMA is 0.54, which makes it a Buy.
  • Spero Therapeutics 50-day exponential moving average is 0.23 while SPRO share price is 3.04, making it a Buy technically.
  • SPRO stock price is 3.04 and Spero Therapeutics 200-day simple moving average is 0.06, creating a Buy signal.

Fundamental Analysis of Spero Therapeutics

Is Spero Therapeutics a good investment?

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $1.14 per share.

Technical Analysis of Spero Therapeutics

Should I short Spero Therapeutics stock?

* Spero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.